🇺🇸 FDA
Pipeline program

semaglutide combined with metformin

KYLLPJ2025-033

Approved small_molecule active

Quick answer

semaglutide combined with metformin for Osteoporosis is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Osteoporosis
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials